Morag Park

20.4k total citations · 2 hit papers
202 papers, 13.4k citations indexed

About

Morag Park is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Morag Park has authored 202 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Molecular Biology, 76 papers in Oncology and 52 papers in Hepatology. Recurrent topics in Morag Park's work include Liver physiology and pathology (52 papers), Cancer Cells and Metastasis (35 papers) and PI3K/AKT/mTOR signaling in cancer (25 papers). Morag Park is often cited by papers focused on Liver physiology and pathology (52 papers), Cancer Cells and Metastasis (35 papers) and PI3K/AKT/mTOR signaling in cancer (25 papers). Morag Park collaborates with scholars based in Canada, United States and Belgium. Morag Park's co-authors include Monica A. Naujokas, Nicholas Bertos, Isabelle Royal, George F. Vande Woude, Donald G. Blair, Michael Hallett, Colin S. Cooper, Jasmine V. Abella, Pascal Peschard and Atilla Ömeroğlu and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Morag Park

198 papers receiving 13.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stromal gene expression predicts clinical outcome in breast cancer

2008 1.3k citations Nicholas Bertos, François Pépin et al. profile →
Molecular cloning of a new transforming gene from a chemically transformed human cell line

1984 808 citations Morag Park, George F. Vande Woude et al. profile →

Peers

Countries citing papers authored by Morag Park

Since Specialization

Citations

This map shows the geographic impact of Morag Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morag Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morag Park more than expected).

Fields of papers citing papers by Morag Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morag Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morag Park. The network helps show where Morag Park may publish in the future.

Co-authorship network of co-authors of Morag Park

This figure shows the co-authorship network connecting the top 25 collaborators of Morag Park. A scholar is included among the top collaborators of Morag Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morag Park. Morag Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer 2023 ·Immunity ·Tarek Taifour, Sherif Samer Attalla, Dongmei Zuo, (unknown), Virginie Sanguin‐Gendreau, (unknown), (unknown), Tung Bui, Hellen Kuasne, Vasilios Papavasiliou, Chun Geun Lee, Suchitra Kamle, Peter M. Siegel, Jack A. Elias, Morag Park, William J. Muller	70
2	Stromal p53 Regulates Breast Cancer Development, the Immune Landscape, and Survival in an Oncogene-Specific Manner 2022 ·Molecular Cancer Research ·Jinghai Wu, Xin Liu, Julie W. Reeser, Anthony J. Trimboli, Thierry Pécot, Gina M. Sizemore, Shan K. Naidu, Soledad Fernández, Lianbo Yu, Michael Hallett, Morag Park, Gustavo Leone, Blake E. Hildreth, Michael C. Ostrowski	5
3	Co-dependency for MET and FGFR1 in basal triple-negative breast cancers 2021 ·npj Breast Cancer ·(unknown), (unknown), Radia Marie Johnson, (unknown), Sadiq M.I. Saleh, Paul Savage, Anie Monast, Dongmei Zuo, Stéphanie Duhamel, Morag Park	11
4	Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels 2021 ·Proceedings of the National Academy of Sciences ·Marie-Anne Goyette, Islam E. Elkholi, (unknown), Hellen Kuasne, Carla V. Rothlin, William J. Muller, Darren E. Richard, Morag Park, Jean‐Philippe Gratton, Jean‐François Côté	51
5	Elevated V–ATPase Activity Following PTEN Loss Is Required for Enhanced Oncogenic Signaling in Breast Cancer 2020 ·Molecular Cancer Research ·(unknown), (unknown), Nicholas Bertos, Wissal El-Assaad, (unknown), Harvey W. Smith, Jieyi Yang, (unknown), Isabelle Gamache, (unknown), Bruno Gagnon, Tina Gruosso, Michel L. Tremblay, Nahum Sonenberg, Marie‐Christine Guiot, William J. Muller, Morag Park, Jose G. Teodoro	7
6	Infiltration of CD8 ⁺ T cells into tumor cell clusters in triple-negative breast cancer 2019 ·Proceedings of the National Academy of Sciences ·Xuefei Li, Tina Gruosso, Dongmei Zuo, Atilla Ömeroğlu, Sarkis Meterissian, Marie‐Christine Guiot, (unknown), Morag Park, Herbert Levine	91
7	eIF4A Inhibitors Suppress Cell-Cycle Feedback Response and Acquired Resistance to CDK4/6 Inhibition in Cancer 2019 ·Molecular Cancer Therapeutics ·Tim Kong, Yibo Xue, Regina Cencic, Xianbing Zhu, Anie Monast, Zheng Qing Fu, (unknown), Veena Sangwan, Marie‐Christine Guiot, William D. Foulkes, John A. Porco, Morag Park, Jerry Pelletier, Sidong Huang	33
8	CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers 2019 ·Cancer Research ·Tim Kong, Ryuhjin Ahn, (unknown), Xianbing Zhu, Zheng Fu, Geneviève Morin, (unknown), (unknown), Yibo Xue, Hellen Kuasne, Qinghao Li, Sungmi Jung, Anne V. Gonzalez, Sophie Camilleri‐Broët, Marie‐Christine Guiot, Morag Park, Josie Ursini‐Siegel, Sidong Huang	103
9	Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas 2018 ·Clinical Cancer Research ·Matthew Dankner, Mathieu Lajoie, Dan Moldoveanu, (unknown), Paul Savage, Shivshankari Rajkumar, Xiu Huang, Maria Lvova, Alexei Protopopov, Dana Vuzman, David Hogg, Morag Park, Marie‐Christine Guiot, Kevin Petrecca, Catalin Mihalcioiu, Ian R. Watson, Peter M. Siegel, April A. N. Rose	47
10	Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss 2018 ·Cancer Research ·Bhavna Murali, Qihao Ren, Xianmin Luo, Douglas V. Faget, Chun Wang, Radia Marie Johnson, Tina Gruosso, Kevin C. Flanagan, Yujie Fu, K. Leahy, Elise Alspach, Xinming Su, Michael H. Ross, Barry Burnette, Katherine N. Weilbaecher, Morag Park, Gabriel Mbalaviele, Joseph B. Monahan, Sheila A. Stewart	49
11	CrosstalkNet: A Visualization Tool for Differential Co-expression Networks and Communities 2018 ·Cancer Research ·Venkata Manem, George Alexandru Adam, Tina Gruosso, Mathieu Gigoux, Nicholas Bertos, Morag Park, Benjamin Haibe‐Kains	1
12	Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms 2017 ·Molecular Cancer Therapeutics ·Michael M. Grandal, (unknown), Thomas T. Poulsen, Klaus Koefoed, Anna Dahlman, Gunther R. Galler, Paolo Conrotto, Sara Collins, Karsten W. Eriksen, Dafna Kaufman, George F. Vande Woude, Helle J. Jacobsen, Ivan D. Horak, Michael Kragh, Johan Lantto, Thomas Bouquin, Morag Park, Mikkel W. Pedersen	23
13	Identification of Interacting Stromal Axes in Triple-Negative Breast Cancer 2017 ·Cancer Research ·Sadiq M.I. Saleh, Nicholas Bertos, Tina Gruosso, Mathieu Gigoux, Margarita Souleimanova, Hong Zhao, Atilla Ömeroğlu, Michael Hallett, Morag Park	22
14	Regulation of Cell Migration and β1 Integrin Trafficking by the Endosomal Adaptor GGA3 2016 ·Traffic ·Colin D.H. Ratcliffe, Pranshu Sahgal, Christine A. Parachoniak, Johanna Ivaska, Morag Park	34
15	Second primary cancer in patients with head and neck squamous cell carcinoma (review of the literature) 2014 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Morag Park	0
16	Accumulation of Multipotent Progenitors with a Basal Differentiation Bias during Aging of Human Mammary Epithelia 2012 ·Cancer Research ·James C. Garbe, François Pépin, (unknown), (unknown), Agla J. Fridriksdottir, Diana E. Guo, René Villadsen, Morag Park, Ole W. Petersen, Alexander D. Borowsky, Martha R. Stampfer, Mark A. LaBarge	80
17	Receptor Tyrosine Kinase Signaling Favors a Protumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response 2010 ·Cancer Research ·Josie Ursini‐Siegel, Sean Cory, Dongmei Zuo, W. Rod Hardy, Elton Rexhepaj, Sonya H.L. Lam, Babette Schade, Karin Jirström, Eva Bjur, Ciriaco A. Piccirillo, David G. DeNardo, Lisa M. Coussens, Donal J. Brennan, William M. Gallagher, Morag Park, Tony Pawson, Michael Hallett, William J. Muller	24
18	Overexpression of the Protein Tyrosine Phosphatase PRL-2 Correlates with Breast Tumor Formation and Progression 2010 ·Cancer Research ·Serge Hardy, (unknown), William J. Muller, Morag Park, Michel L. Tremblay	54
19	Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer 2010 ·Clinical Cancer Research ·April A. N. Rose, Andrée‐Anne Grosset, Zhifeng Dong, Caterina Russo, Patricia MacDonald, Nicholas Bertos, Yves St‐Pierre, Ronit Simantov, Michael Hallett, Morag Park, Louis Gaboury, Peter M. Siegel	157
20	Genome-Wide Identification of Direct Target Genes Implicates Estrogen-Related Receptor α as a Determinant of Breast Cancer Heterogeneity 2009 ·Cancer Research ·Geneviève Deblois, Jacqueline A. Hall, (unknown), Josée Laganière, Majid Ghahremani, Morag Park, Michael Hallett, Vincent Giguère	143

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact